United States Biotechnology & Medical Research

Beam Therapeutics Inc (BEAM)

Track

Over the past 90 days, Beam Therapeutics Inc. experienced significant insider selling, with a net value of approximately $10.04 million. Key transactions included multiple planned and proposed sales by CEO John M. Evans and other officers. These activities occurred following the company's May 2026 results financiers, amid a 14.7% decline in stock price.
Ticker: BEAM Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Beam Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 27 Jul 2026
Value US$2,689,804.94 | Price 20.18 | Shares 7,842 (-6.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-29 2026-07-27 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
7,842 -6.0%
20.18
US$2,689,805 		7,842 -6.0% 20.18 US$2,689,805
2026-07-27 2026-07-27 PrS Proposed sale
AMY SIMON

Officer

Officer
88,870
137.24
US$3,717,581 		88,870 137.24 US$3,717,581
2026-07-02 2026-06-30 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
42,923 +45.2%
309.97
US$3,846,812 		42,923 +45.2% 309.97 US$3,846,812
2026-07-01 2026-06-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
1,900 -0.2%
34.84
US$66,203 		1,900 -0.2% 34.84 US$66,203
2026-07-01 2026-06-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
23,100 -2.2%
34.26
US$791,482 		23,100 -2.2% 34.26 US$791,482
2026-06-30 2026-06-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
34.31
US$857,685 		25,000 34.31 US$857,685
2026-07-01 2026-06-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
11,579 -1.1%
35.91
US$415,824 		11,579 -1.1% 35.91 US$415,824
2026-07-01 2026-06-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
13,421 -1.3%
35.13
US$471,528 		13,421 -1.3% 35.13 US$471,528
2026-06-29 2026-06-29 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
35.49
US$887,352 		25,000 35.49 US$887,352
2026-06-29 2026-06-26 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
251,488 -22.7%
35.26
US$8,867,467 		251,488 -22.7% 35.26 US$8,867,467
2026-06-29 2026-06-25 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
33,372 -2.9%
35.12
US$1,172,025 		33,372 -2.9% 35.12 US$1,172,025
2026-04-14 2026-04-14 PrS Proposed sale
3.9
CAROLE HO

Director

Non-Executive Director
87,784
30.73
US$2,698,015 		87,784 30.73 US$2,698,015
2026-03-31 2026-04-02 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
20,000
21.90
US$438,000 		20,000 21.90 US$438,000
2026-03-31 2026-04-02 PrS Proposed sale
2.5
GIUSEPPE CIARAMELLA

Officer

Officer
26,250
21.90
US$574,875 		26,250 21.90 US$574,875
2026-03-31 2026-04-02 PrS Proposed sale
2.5
JOHN M. EVANS

Officer; Director

Executive Director
66,874
21.90
US$1,464,541 		66,874 21.90 US$1,464,541
2026-03-31 2026-04-02 PrS Proposed sale
AMY SIMON

Officer

Officer
20,000
21.90
US$438,000 		20,000 21.90 US$438,000
2026-04-06 2026-04-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,242 -6.0%
24.58
US$79,688 		3,242 -6.0% 24.58 US$79,688
2026-04-06 2026-04-01 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
11,810 -5.1%
24.58
US$290,290 		11,810 -5.1% 24.58 US$290,290
2026-04-06 2026-04-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
30,078 -2.8%
24.58
US$739,317 		30,078 -2.8% 24.58 US$739,317
2026-04-06 2026-04-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
6,700 -6.1%
24.58
US$164,686 		6,700 -6.1% 24.58 US$164,686
2026-04-06 2026-04-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
5,956 -5.1%
24.58
US$146,398 		5,956 -5.1% 24.58 US$146,398
2026-04-01 2026-03-31 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
22.76
US$569,085 		25,000 -2.5% 22.76 US$569,085
2026-03-31 2026-03-31 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
22.76
US$569,085 		25,000 22.76 US$569,085
2026-04-01 2026-03-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
22.37
US$559,230 		25,000 -2.5% 22.37 US$559,230
2026-03-30 2026-03-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
22.37
US$559,230 		25,000 22.37 US$559,230
2026-02-26 2026-02-24 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
35,000 -15.5%
32.00
US$1,120,042 		35,000 -15.5% 32.00 US$1,120,042
2026-02-24 2026-02-24 PrS Proposed sale
2.5
GIUSEPPE CIARAMELLA

Officer

Officer
35,000
32.00
US$1,120,042 		35,000 32.00 US$1,120,042
2026-02-02 2026-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
2,906 -0.3%
29.00
US$84,274 		2,906 -0.3% 29.00 US$84,274
2026-02-02 2026-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
22,094 -2.2%
28.27
US$624,672 		22,094 -2.2% 28.27 US$624,672
2026-01-30 2026-01-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
28.36
US$708,948 		25,000 28.36 US$708,948
2026-02-02 2026-01-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
8,667 -0.9%
29.74
US$257,781 		8,667 -0.9% 29.74 US$257,781
2026-02-02 2026-01-29 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
16,333 -1.6%
29.19
US$476,801 		16,333 -1.6% 29.19 US$476,801
2026-01-29 2026-01-29 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
29.38
US$734,582 		25,000 29.38 US$734,582
2026-01-26 2026-01-22 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,371 -1.4%
34.00
US$46,614 		1,371 -1.4% 34.00 US$46,614
2026-01-26 2026-01-22 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
6,198 -15.1%
35.00
US$216,933 		6,198 -15.1% 35.00 US$216,933
2026-01-22 2026-01-22 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
1,371
34.00
US$46,614 		1,371 34.00 US$46,614
2026-01-21 2026-01-20 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,034 -6.9%
30.12
US$91,384 		3,034 -6.9% 30.12 US$91,384
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
559 -0.6%
35.40
US$19,788 		559 -0.6% 35.40 US$19,788
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
15,959 -14.1%
34.72
US$554,068 		15,959 -14.1% 34.72 US$554,068
2026-01-20 2026-01-15 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
2,111 -1.8%
33.62
US$70,976 		2,111 -1.8% 33.62 US$70,976
2026-01-15 2026-01-15 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
18,629
34.61
US$644,831 		18,629 34.61 US$644,831
2026-01-05 2025-12-31 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,254 -1.1%
27.10
US$33,983 		1,254 -1.1% 27.10 US$33,983
2026-01-05 2025-12-31 PlS Planned sale
2.2
Emany Sravan Kumar

Chief Financial Officer

Officer
6,294 -7.9%
27.10
US$170,567 		6,294 -7.9% 27.10 US$170,567
2025-10-29 2025-10-27 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
459 -97.0%
26.68
US$12,246 		459 -97.0% 26.68 US$12,246
2025-10-03 2025-10-02 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
24.63
US$615,668 		25,000 -2.5% 24.63 US$615,668
2025-10-02 2025-10-02 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
24.63
US$615,668 		25,000 24.63 US$615,668
2025-10-03 2025-10-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
373 -0.3%
24.53
US$9,150 		373 -0.3% 24.53 US$9,150
2025-10-03 2025-10-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
467 -1.0%
24.53
US$11,456 		467 -1.0% 24.53 US$11,456
2025-10-03 2025-10-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
25,000 -2.5%
24.51
US$612,655 		25,000 -2.5% 24.51 US$612,655
2025-10-01 2025-10-01 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
25,000
24.51
US$612,655 		25,000 24.51 US$612,655
2025-08-01 2025-07-30 S Sale
3.5
FMR LLC

See Remark 1

Large shareholder
48,374 -2.3%
20.50
US$991,667 		48,374 -2.3% 20.50 US$991,667
2025-07-03 2025-07-03 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
876 -1.3%
20.12
US$17,625 		876 -1.3% 20.12 US$17,625
2025-07-03 2025-07-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
374 -0.6%
16.94
US$6,336 		374 -0.6% 16.94 US$6,336
2025-04-03 2025-04-02 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
20,997 -24.2%
17.73
US$372,294 		20,997 -24.2% 17.73 US$372,294
2025-04-02 2025-04-02 PrS Proposed sale
AMY SIMON

Officer

Officer
20,997
17.73
US$372,294 		20,997 17.73 US$372,294
2025-04-03 2025-04-01 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
7,434 -3.8%
18.35
US$136,418 		7,434 -3.8% 18.35 US$136,418
2025-04-03 2025-04-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
3,015 -6.3%
18.35
US$55,330 		3,015 -6.3% 18.35 US$55,330
2025-04-03 2025-04-01 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
5,674 -4.6%
18.35
US$104,122 		5,674 -4.6% 18.35 US$104,122
2025-04-03 2025-04-01 PlS Planned sale
Simon Amy

Chief Medical Officer

Officer
9,566 -9.9%
18.35
US$175,542 		9,566 -9.9% 18.35 US$175,542
2025-04-03 2025-04-01 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
30,663 -3.0%
18.35
US$562,684 		30,663 -3.0% 18.35 US$562,684
2025-02-20 2025-02-18 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
6,287 -14.3%
35.00
US$220,045 		6,287 -14.3% 35.00 US$220,045
2025-02-19 2025-02-14 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
10,000 -8.9%
34.00
US$340,000 		10,000 -8.9% 34.00 US$340,000
2025-02-14 2025-02-14 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
10,000
34.00
US$340,000 		10,000 34.00 US$340,000
2025-02-03 2025-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
200 -0.0%
27.28
US$5,456 		200 -0.0% 27.28 US$5,456
2025-02-03 2025-01-30 PlS Planned sale
2.5
Evans John M.

CEO

Executive Director
29,800 -3.2%
26.75
US$797,028 		29,800 -3.2% 26.75 US$797,028
2025-01-30 2025-01-30 PrS Proposed sale
2.5
JOHN M EVANS

Officer; Director

Executive Director
30,000
26.75
US$802,482 		30,000 26.75 US$802,482
2025-01-06 2025-01-02 PlS Planned sale
Bellon Christine

Chief Legal Officer

Officer
1,241 -1.2%
24.68
US$30,628 		1,241 -1.2% 24.68 US$30,628
2025-01-06 2025-01-02 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
1,117 -2.5%
24.68
US$27,568 		1,117 -2.5% 24.68 US$27,568
2024-12-30 2024-12-31 PrS Proposed sale
BETHANY J. CAVANAGH

Officer

Officer
9,500
25.27
US$240,065 		9,500 25.27 US$240,065
2024-12-30 2024-12-31 PrS Proposed sale
CHRISTINE BELLON

Officer

Officer
4,167
25.27
US$105,300 		4,167 25.27 US$105,300
2024-11-08 2024-11-06 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
51,110 -31.9%
26.36
US$1,347,050 		51,110 -31.9% 26.36 US$1,347,050
2024-10-16 2024-10-14 PlS Planned sale
2.5
Ciaramella Giuseppe

President

Officer
51,110 -24.2%
26.27
US$1,342,752 		51,110 -24.2% 26.27 US$1,342,752
2024-10-15 2024-10-14 PrS Proposed sale
2.5
Giuseppe Ciaramella

Officer

Officer
102,220
24.65
US$2,519,723 		102,220 24.65 US$2,519,723
2024-10-07 2024-10-07 PrS Proposed sale
2.5
Burrell Terry-Ann

Officer

Officer
185,565
23.00
US$4,267,995 		185,565 23.00 US$4,267,995
2024-10-02 2024-10-01 PlS Planned sale
Cavanagh Bethany J

SVP, Finance and Treasurer

Officer
289 -0.6%
23.48
US$6,785 		289 -0.6% 23.48 US$6,785
Explore more

More insider trading research around Beam Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America